nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Vincristine—colon cancer	0.366	0.574	CbGbCtD
Bosentan—CYP2C9—Capecitabine—colon cancer	0.12	0.188	CbGbCtD
Bosentan—CYP2C9—Fluorouracil—colon cancer	0.0709	0.111	CbGbCtD
Bosentan—CYP3A4—Irinotecan—colon cancer	0.0429	0.0675	CbGbCtD
Bosentan—CYP3A4—Vincristine—colon cancer	0.0375	0.059	CbGbCtD
Bosentan—ABCB11—bile—colon cancer	0.0327	0.556	CbGeAlD
Bosentan—EDNRB—vagina—colon cancer	0.0039	0.0664	CbGeAlD
Bosentan—ABCB11—digestive system—colon cancer	0.00357	0.0607	CbGeAlD
Bosentan—EDNRB—liver—colon cancer	0.00329	0.056	CbGeAlD
Bosentan—EDNRA—vagina—colon cancer	0.00323	0.0549	CbGeAlD
Bosentan—ABCB11—liver—colon cancer	0.00266	0.0452	CbGeAlD
Bosentan—EDNRB—lymph node—colon cancer	0.00252	0.043	CbGeAlD
Bosentan—EDNRA—lymph node—colon cancer	0.00209	0.0355	CbGeAlD
Bosentan—CYP2C9—digestive system—colon cancer	0.00121	0.0206	CbGeAlD
Bosentan—CYP3A4—renal system—colon cancer	0.00112	0.0191	CbGeAlD
Bosentan—CYP3A4—digestive system—colon cancer	0.000922	0.0157	CbGeAlD
Bosentan—CYP2C9—liver—colon cancer	0.0009	0.0153	CbGeAlD
Bosentan—CYP3A4—liver—colon cancer	0.000687	0.0117	CbGeAlD
Bosentan—Acute coronary syndrome—Capecitabine—colon cancer	0.00059	0.00193	CcSEcCtD
Bosentan—Lethargy—Methotrexate—colon cancer	0.00059	0.00193	CcSEcCtD
Bosentan—Cerebrovascular accident—Methotrexate—colon cancer	0.00059	0.00193	CcSEcCtD
Bosentan—Renal failure—Capecitabine—colon cancer	0.000588	0.00193	CcSEcCtD
Bosentan—Discomfort—Irinotecan—colon cancer	0.000588	0.00193	CcSEcCtD
Bosentan—Myocardial infarction—Capecitabine—colon cancer	0.000586	0.00192	CcSEcCtD
Bosentan—Anaphylactic shock—Vincristine—colon cancer	0.000585	0.00192	CcSEcCtD
Bosentan—Oedema—Vincristine—colon cancer	0.000585	0.00192	CcSEcCtD
Bosentan—Stomatitis—Capecitabine—colon cancer	0.000583	0.00191	CcSEcCtD
Bosentan—Jaundice—Capecitabine—colon cancer	0.000583	0.00191	CcSEcCtD
Bosentan—Infection—Vincristine—colon cancer	0.000582	0.00191	CcSEcCtD
Bosentan—Urinary tract infection—Capecitabine—colon cancer	0.000581	0.00191	CcSEcCtD
Bosentan—Conjunctivitis—Capecitabine—colon cancer	0.000581	0.00191	CcSEcCtD
Bosentan—Nervous system disorder—Vincristine—colon cancer	0.000574	0.00188	CcSEcCtD
Bosentan—Thrombocytopenia—Vincristine—colon cancer	0.000573	0.00188	CcSEcCtD
Bosentan—Haematuria—Capecitabine—colon cancer	0.00057	0.00187	CcSEcCtD
Bosentan—Anaphylactic shock—Irinotecan—colon cancer	0.00057	0.00187	CcSEcCtD
Bosentan—Oedema—Irinotecan—colon cancer	0.00057	0.00187	CcSEcCtD
Bosentan—Chest pain—Fluorouracil—colon cancer	0.00057	0.00187	CcSEcCtD
Bosentan—Infection—Irinotecan—colon cancer	0.000566	0.00186	CcSEcCtD
Bosentan—Hyperhidrosis—Vincristine—colon cancer	0.000566	0.00186	CcSEcCtD
Bosentan—Hepatobiliary disease—Capecitabine—colon cancer	0.000566	0.00186	CcSEcCtD
Bosentan—Epistaxis—Capecitabine—colon cancer	0.000564	0.00185	CcSEcCtD
Bosentan—Discomfort—Fluorouracil—colon cancer	0.000563	0.00185	CcSEcCtD
Bosentan—Shock—Irinotecan—colon cancer	0.000561	0.00184	CcSEcCtD
Bosentan—Nervous system disorder—Irinotecan—colon cancer	0.000559	0.00183	CcSEcCtD
Bosentan—Thrombocytopenia—Irinotecan—colon cancer	0.000558	0.00183	CcSEcCtD
Bosentan—Anorexia—Vincristine—colon cancer	0.000558	0.00183	CcSEcCtD
Bosentan—Irritability—Methotrexate—colon cancer	0.000552	0.00181	CcSEcCtD
Bosentan—Hyperhidrosis—Irinotecan—colon cancer	0.000551	0.00181	CcSEcCtD
Bosentan—Mood swings—Methotrexate—colon cancer	0.000547	0.0018	CcSEcCtD
Bosentan—Hypotension—Vincristine—colon cancer	0.000547	0.00179	CcSEcCtD
Bosentan—Bradycardia—Capecitabine—colon cancer	0.000547	0.00179	CcSEcCtD
Bosentan—Anaphylactic shock—Fluorouracil—colon cancer	0.000546	0.00179	CcSEcCtD
Bosentan—Oedema—Fluorouracil—colon cancer	0.000546	0.00179	CcSEcCtD
Bosentan—Anorexia—Irinotecan—colon cancer	0.000543	0.00178	CcSEcCtD
Bosentan—Infection—Fluorouracil—colon cancer	0.000542	0.00178	CcSEcCtD
Bosentan—Haemoglobin—Capecitabine—colon cancer	0.00054	0.00177	CcSEcCtD
Bosentan—Hepatitis—Capecitabine—colon cancer	0.000537	0.00176	CcSEcCtD
Bosentan—Haemorrhage—Capecitabine—colon cancer	0.000537	0.00176	CcSEcCtD
Bosentan—Nervous system disorder—Fluorouracil—colon cancer	0.000535	0.00176	CcSEcCtD
Bosentan—Thrombocytopenia—Fluorouracil—colon cancer	0.000535	0.00175	CcSEcCtD
Bosentan—Hypoaesthesia—Capecitabine—colon cancer	0.000534	0.00175	CcSEcCtD
Bosentan—Liver function test abnormal—Methotrexate—colon cancer	0.000534	0.00175	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Vincristine—colon cancer	0.000533	0.00175	CcSEcCtD
Bosentan—Tachycardia—Fluorouracil—colon cancer	0.000533	0.00175	CcSEcCtD
Bosentan—Hypotension—Irinotecan—colon cancer	0.000533	0.00175	CcSEcCtD
Bosentan—Urinary tract disorder—Capecitabine—colon cancer	0.00053	0.00174	CcSEcCtD
Bosentan—Insomnia—Vincristine—colon cancer	0.000529	0.00174	CcSEcCtD
Bosentan—Oedema peripheral—Capecitabine—colon cancer	0.000529	0.00174	CcSEcCtD
Bosentan—Urethral disorder—Capecitabine—colon cancer	0.000526	0.00173	CcSEcCtD
Bosentan—Paraesthesia—Vincristine—colon cancer	0.000526	0.00172	CcSEcCtD
Bosentan—Anorexia—Fluorouracil—colon cancer	0.00052	0.00171	CcSEcCtD
Bosentan—Insomnia—Irinotecan—colon cancer	0.000516	0.00169	CcSEcCtD
Bosentan—Paraesthesia—Irinotecan—colon cancer	0.000512	0.00168	CcSEcCtD
Bosentan—Hypotension—Fluorouracil—colon cancer	0.00051	0.00167	CcSEcCtD
Bosentan—Decreased appetite—Vincristine—colon cancer	0.000509	0.00167	CcSEcCtD
Bosentan—Dyspnoea—Irinotecan—colon cancer	0.000508	0.00167	CcSEcCtD
Bosentan—Erythema multiforme—Capecitabine—colon cancer	0.000508	0.00167	CcSEcCtD
Bosentan—Somnolence—Irinotecan—colon cancer	0.000507	0.00166	CcSEcCtD
Bosentan—Gastrointestinal disorder—Vincristine—colon cancer	0.000505	0.00166	CcSEcCtD
Bosentan—Fatigue—Vincristine—colon cancer	0.000505	0.00166	CcSEcCtD
Bosentan—Eye disorder—Capecitabine—colon cancer	0.000502	0.00165	CcSEcCtD
Bosentan—Dyspepsia—Irinotecan—colon cancer	0.000502	0.00165	CcSEcCtD
Bosentan—Tinnitus—Capecitabine—colon cancer	0.000501	0.00164	CcSEcCtD
Bosentan—Pain—Vincristine—colon cancer	0.000501	0.00164	CcSEcCtD
Bosentan—Constipation—Vincristine—colon cancer	0.000501	0.00164	CcSEcCtD
Bosentan—Asthma—Methotrexate—colon cancer	0.000499	0.00164	CcSEcCtD
Bosentan—Cardiac disorder—Capecitabine—colon cancer	0.000498	0.00163	CcSEcCtD
Bosentan—Flushing—Capecitabine—colon cancer	0.000498	0.00163	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000497	0.00163	CcSEcCtD
Bosentan—Decreased appetite—Irinotecan—colon cancer	0.000496	0.00163	CcSEcCtD
Bosentan—Eosinophilia—Methotrexate—colon cancer	0.000495	0.00162	CcSEcCtD
Bosentan—Insomnia—Fluorouracil—colon cancer	0.000494	0.00162	CcSEcCtD
Bosentan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000492	0.00161	CcSEcCtD
Bosentan—Fatigue—Irinotecan—colon cancer	0.000491	0.00161	CcSEcCtD
Bosentan—Paraesthesia—Fluorouracil—colon cancer	0.00049	0.00161	CcSEcCtD
Bosentan—Pain—Irinotecan—colon cancer	0.000487	0.0016	CcSEcCtD
Bosentan—Constipation—Irinotecan—colon cancer	0.000487	0.0016	CcSEcCtD
Bosentan—Angiopathy—Capecitabine—colon cancer	0.000487	0.0016	CcSEcCtD
Bosentan—Dyspnoea—Fluorouracil—colon cancer	0.000487	0.0016	CcSEcCtD
Bosentan—Somnolence—Fluorouracil—colon cancer	0.000485	0.00159	CcSEcCtD
Bosentan—Immune system disorder—Capecitabine—colon cancer	0.000485	0.00159	CcSEcCtD
Bosentan—Mediastinal disorder—Capecitabine—colon cancer	0.000484	0.00159	CcSEcCtD
Bosentan—Chills—Capecitabine—colon cancer	0.000482	0.00158	CcSEcCtD
Bosentan—Dyspepsia—Fluorouracil—colon cancer	0.000481	0.00158	CcSEcCtD
Bosentan—Gastrointestinal pain—Vincristine—colon cancer	0.000479	0.00157	CcSEcCtD
Bosentan—Decreased appetite—Fluorouracil—colon cancer	0.000475	0.00156	CcSEcCtD
Bosentan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000471	0.00155	CcSEcCtD
Bosentan—Mental disorder—Capecitabine—colon cancer	0.00047	0.00154	CcSEcCtD
Bosentan—Erythema—Capecitabine—colon cancer	0.000467	0.00153	CcSEcCtD
Bosentan—Malnutrition—Capecitabine—colon cancer	0.000467	0.00153	CcSEcCtD
Bosentan—Neutropenia—Methotrexate—colon cancer	0.000467	0.00153	CcSEcCtD
Bosentan—Dysuria—Methotrexate—colon cancer	0.000467	0.00153	CcSEcCtD
Bosentan—Pain—Fluorouracil—colon cancer	0.000467	0.00153	CcSEcCtD
Bosentan—Gastrointestinal pain—Irinotecan—colon cancer	0.000466	0.00153	CcSEcCtD
Bosentan—Upper respiratory tract infection—Methotrexate—colon cancer	0.000464	0.00152	CcSEcCtD
Bosentan—Body temperature increased—Vincristine—colon cancer	0.000463	0.00152	CcSEcCtD
Bosentan—Abdominal pain—Vincristine—colon cancer	0.000463	0.00152	CcSEcCtD
Bosentan—Flatulence—Capecitabine—colon cancer	0.000461	0.00151	CcSEcCtD
Bosentan—Back pain—Capecitabine—colon cancer	0.000452	0.00148	CcSEcCtD
Bosentan—Abdominal pain—Irinotecan—colon cancer	0.000451	0.00148	CcSEcCtD
Bosentan—Body temperature increased—Irinotecan—colon cancer	0.000451	0.00148	CcSEcCtD
Bosentan—Muscle spasms—Capecitabine—colon cancer	0.000449	0.00147	CcSEcCtD
Bosentan—Pneumonia—Methotrexate—colon cancer	0.000448	0.00147	CcSEcCtD
Bosentan—Infestation NOS—Methotrexate—colon cancer	0.000445	0.00146	CcSEcCtD
Bosentan—Infestation—Methotrexate—colon cancer	0.000445	0.00146	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000442	0.00145	CcSEcCtD
Bosentan—Vision blurred—Capecitabine—colon cancer	0.000441	0.00145	CcSEcCtD
Bosentan—Tremor—Capecitabine—colon cancer	0.000438	0.00144	CcSEcCtD
Bosentan—Renal failure—Methotrexate—colon cancer	0.000438	0.00144	CcSEcCtD
Bosentan—Stomatitis—Methotrexate—colon cancer	0.000434	0.00142	CcSEcCtD
Bosentan—Urticaria—Fluorouracil—colon cancer	0.000434	0.00142	CcSEcCtD
Bosentan—Conjunctivitis—Methotrexate—colon cancer	0.000433	0.00142	CcSEcCtD
Bosentan—Anaemia—Capecitabine—colon cancer	0.000432	0.00142	CcSEcCtD
Bosentan—Body temperature increased—Fluorouracil—colon cancer	0.000432	0.00142	CcSEcCtD
Bosentan—Hypersensitivity—Vincristine—colon cancer	0.000431	0.00141	CcSEcCtD
Bosentan—Haematuria—Methotrexate—colon cancer	0.000425	0.00139	CcSEcCtD
Bosentan—Hepatobiliary disease—Methotrexate—colon cancer	0.000421	0.00138	CcSEcCtD
Bosentan—Epistaxis—Methotrexate—colon cancer	0.00042	0.00138	CcSEcCtD
Bosentan—Vertigo—Capecitabine—colon cancer	0.00042	0.00138	CcSEcCtD
Bosentan—Hypersensitivity—Irinotecan—colon cancer	0.00042	0.00138	CcSEcCtD
Bosentan—Asthenia—Vincristine—colon cancer	0.00042	0.00138	CcSEcCtD
Bosentan—Syncope—Capecitabine—colon cancer	0.000419	0.00138	CcSEcCtD
Bosentan—Leukopenia—Capecitabine—colon cancer	0.000418	0.00137	CcSEcCtD
Bosentan—Palpitations—Capecitabine—colon cancer	0.000413	0.00136	CcSEcCtD
Bosentan—Loss of consciousness—Capecitabine—colon cancer	0.000411	0.00135	CcSEcCtD
Bosentan—Asthenia—Irinotecan—colon cancer	0.000409	0.00134	CcSEcCtD
Bosentan—Cough—Capecitabine—colon cancer	0.000408	0.00134	CcSEcCtD
Bosentan—Hypersensitivity—Fluorouracil—colon cancer	0.000402	0.00132	CcSEcCtD
Bosentan—Haemoglobin—Methotrexate—colon cancer	0.000402	0.00132	CcSEcCtD
Bosentan—Diarrhoea—Vincristine—colon cancer	0.000401	0.00131	CcSEcCtD
Bosentan—Haemorrhage—Methotrexate—colon cancer	0.0004	0.00131	CcSEcCtD
Bosentan—Hepatitis—Methotrexate—colon cancer	0.0004	0.00131	CcSEcCtD
Bosentan—Chest pain—Capecitabine—colon cancer	0.000398	0.00131	CcSEcCtD
Bosentan—Arthralgia—Capecitabine—colon cancer	0.000398	0.00131	CcSEcCtD
Bosentan—Anxiety—Capecitabine—colon cancer	0.000397	0.0013	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000395	0.0013	CcSEcCtD
Bosentan—Urinary tract disorder—Methotrexate—colon cancer	0.000395	0.0013	CcSEcCtD
Bosentan—Discomfort—Capecitabine—colon cancer	0.000393	0.00129	CcSEcCtD
Bosentan—Urethral disorder—Methotrexate—colon cancer	0.000392	0.00129	CcSEcCtD
Bosentan—Diarrhoea—Irinotecan—colon cancer	0.00039	0.00128	CcSEcCtD
Bosentan—Dry mouth—Capecitabine—colon cancer	0.000389	0.00128	CcSEcCtD
Bosentan—Dizziness—Vincristine—colon cancer	0.000387	0.00127	CcSEcCtD
Bosentan—Pruritus—Fluorouracil—colon cancer	0.000386	0.00127	CcSEcCtD
Bosentan—Oedema—Capecitabine—colon cancer	0.000382	0.00125	CcSEcCtD
Bosentan—Infection—Capecitabine—colon cancer	0.000379	0.00124	CcSEcCtD
Bosentan—Erythema multiforme—Methotrexate—colon cancer	0.000378	0.00124	CcSEcCtD
Bosentan—Dizziness—Irinotecan—colon cancer	0.000377	0.00124	CcSEcCtD
Bosentan—Shock—Capecitabine—colon cancer	0.000375	0.00123	CcSEcCtD
Bosentan—Nervous system disorder—Capecitabine—colon cancer	0.000374	0.00123	CcSEcCtD
Bosentan—Eye disorder—Methotrexate—colon cancer	0.000374	0.00123	CcSEcCtD
Bosentan—Diarrhoea—Fluorouracil—colon cancer	0.000374	0.00123	CcSEcCtD
Bosentan—Thrombocytopenia—Capecitabine—colon cancer	0.000374	0.00123	CcSEcCtD
Bosentan—Tinnitus—Methotrexate—colon cancer	0.000373	0.00122	CcSEcCtD
Bosentan—Tachycardia—Capecitabine—colon cancer	0.000372	0.00122	CcSEcCtD
Bosentan—Vomiting—Vincristine—colon cancer	0.000372	0.00122	CcSEcCtD
Bosentan—Cardiac disorder—Methotrexate—colon cancer	0.000371	0.00122	CcSEcCtD
Bosentan—Skin disorder—Capecitabine—colon cancer	0.000371	0.00122	CcSEcCtD
Bosentan—Rash—Vincristine—colon cancer	0.000369	0.00121	CcSEcCtD
Bosentan—Hyperhidrosis—Capecitabine—colon cancer	0.000369	0.00121	CcSEcCtD
Bosentan—Dermatitis—Vincristine—colon cancer	0.000369	0.00121	CcSEcCtD
Bosentan—Headache—Vincristine—colon cancer	0.000367	0.0012	CcSEcCtD
Bosentan—Anorexia—Capecitabine—colon cancer	0.000364	0.00119	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—colon cancer	0.000363	0.00119	CcSEcCtD
Bosentan—Vomiting—Irinotecan—colon cancer	0.000362	0.00119	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—colon cancer	0.000361	0.00118	CcSEcCtD
Bosentan—Dizziness—Fluorouracil—colon cancer	0.000361	0.00118	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—colon cancer	0.00036	0.00118	CcSEcCtD
Bosentan—Rash—Irinotecan—colon cancer	0.000359	0.00118	CcSEcCtD
Bosentan—Dermatitis—Irinotecan—colon cancer	0.000359	0.00118	CcSEcCtD
Bosentan—Chills—Methotrexate—colon cancer	0.000359	0.00118	CcSEcCtD
Bosentan—Headache—Irinotecan—colon cancer	0.000357	0.00117	CcSEcCtD
Bosentan—Hypotension—Capecitabine—colon cancer	0.000357	0.00117	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—colon cancer	0.00035	0.00115	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—colon cancer	0.000348	0.00114	CcSEcCtD
Bosentan—Erythema—Methotrexate—colon cancer	0.000348	0.00114	CcSEcCtD
Bosentan—Nausea—Vincristine—colon cancer	0.000348	0.00114	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000348	0.00114	CcSEcCtD
Bosentan—Vomiting—Fluorouracil—colon cancer	0.000347	0.00114	CcSEcCtD
Bosentan—Insomnia—Capecitabine—colon cancer	0.000345	0.00113	CcSEcCtD
Bosentan—Rash—Fluorouracil—colon cancer	0.000344	0.00113	CcSEcCtD
Bosentan—Dermatitis—Fluorouracil—colon cancer	0.000344	0.00113	CcSEcCtD
Bosentan—Paraesthesia—Capecitabine—colon cancer	0.000343	0.00112	CcSEcCtD
Bosentan—Headache—Fluorouracil—colon cancer	0.000342	0.00112	CcSEcCtD
Bosentan—Dyspnoea—Capecitabine—colon cancer	0.00034	0.00112	CcSEcCtD
Bosentan—Nausea—Irinotecan—colon cancer	0.000339	0.00111	CcSEcCtD
Bosentan—Back pain—Methotrexate—colon cancer	0.000337	0.0011	CcSEcCtD
Bosentan—Dyspepsia—Capecitabine—colon cancer	0.000336	0.0011	CcSEcCtD
Bosentan—Decreased appetite—Capecitabine—colon cancer	0.000332	0.00109	CcSEcCtD
Bosentan—Gastrointestinal disorder—Capecitabine—colon cancer	0.000329	0.00108	CcSEcCtD
Bosentan—Fatigue—Capecitabine—colon cancer	0.000329	0.00108	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—colon cancer	0.000328	0.00108	CcSEcCtD
Bosentan—Pain—Capecitabine—colon cancer	0.000326	0.00107	CcSEcCtD
Bosentan—Constipation—Capecitabine—colon cancer	0.000326	0.00107	CcSEcCtD
Bosentan—Nausea—Fluorouracil—colon cancer	0.000324	0.00106	CcSEcCtD
Bosentan—Anaemia—Methotrexate—colon cancer	0.000322	0.00106	CcSEcCtD
Bosentan—Vertigo—Methotrexate—colon cancer	0.000313	0.00103	CcSEcCtD
Bosentan—Gastrointestinal pain—Capecitabine—colon cancer	0.000312	0.00102	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—colon cancer	0.000312	0.00102	CcSEcCtD
Bosentan—Cough—Methotrexate—colon cancer	0.000304	0.000996	CcSEcCtD
Bosentan—Urticaria—Capecitabine—colon cancer	0.000303	0.000994	CcSEcCtD
Bosentan—Abdominal pain—Capecitabine—colon cancer	0.000302	0.000989	CcSEcCtD
Bosentan—Body temperature increased—Capecitabine—colon cancer	0.000302	0.000989	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—colon cancer	0.000296	0.000972	CcSEcCtD
Bosentan—Chest pain—Methotrexate—colon cancer	0.000296	0.000972	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000294	0.000965	CcSEcCtD
Bosentan—Discomfort—Methotrexate—colon cancer	0.000293	0.00096	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—colon cancer	0.000284	0.000932	CcSEcCtD
Bosentan—Infection—Methotrexate—colon cancer	0.000282	0.000926	CcSEcCtD
Bosentan—Hypersensitivity—Capecitabine—colon cancer	0.000281	0.000922	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—colon cancer	0.000279	0.000914	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—colon cancer	0.000278	0.000912	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—colon cancer	0.000276	0.000905	CcSEcCtD
Bosentan—Hyperhidrosis—Methotrexate—colon cancer	0.000275	0.000901	CcSEcCtD
Bosentan—Asthenia—Capecitabine—colon cancer	0.000274	0.000898	CcSEcCtD
Bosentan—Anorexia—Methotrexate—colon cancer	0.000271	0.000888	CcSEcCtD
Bosentan—Pruritus—Capecitabine—colon cancer	0.00027	0.000885	CcSEcCtD
Bosentan—Hypotension—Methotrexate—colon cancer	0.000265	0.000871	CcSEcCtD
Bosentan—Diarrhoea—Capecitabine—colon cancer	0.000261	0.000856	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000259	0.000849	CcSEcCtD
Bosentan—Insomnia—Methotrexate—colon cancer	0.000257	0.000843	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—colon cancer	0.000255	0.000837	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—colon cancer	0.000253	0.000831	CcSEcCtD
Bosentan—Somnolence—Methotrexate—colon cancer	0.000252	0.000828	CcSEcCtD
Bosentan—Dizziness—Capecitabine—colon cancer	0.000252	0.000828	CcSEcCtD
Bosentan—Dyspepsia—Methotrexate—colon cancer	0.00025	0.00082	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—colon cancer	0.000247	0.00081	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000245	0.000804	CcSEcCtD
Bosentan—Fatigue—Methotrexate—colon cancer	0.000245	0.000803	CcSEcCtD
Bosentan—Pain—Methotrexate—colon cancer	0.000243	0.000797	CcSEcCtD
Bosentan—Vomiting—Capecitabine—colon cancer	0.000243	0.000796	CcSEcCtD
Bosentan—Rash—Capecitabine—colon cancer	0.000241	0.000789	CcSEcCtD
Bosentan—Dermatitis—Capecitabine—colon cancer	0.00024	0.000788	CcSEcCtD
Bosentan—Headache—Capecitabine—colon cancer	0.000239	0.000784	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—colon cancer	0.000232	0.000762	CcSEcCtD
Bosentan—Nausea—Capecitabine—colon cancer	0.000227	0.000743	CcSEcCtD
Bosentan—Urticaria—Methotrexate—colon cancer	0.000226	0.00074	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—colon cancer	0.000225	0.000736	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—colon cancer	0.000225	0.000736	CcSEcCtD
Bosentan—Hypersensitivity—Methotrexate—colon cancer	0.000209	0.000686	CcSEcCtD
Bosentan—Asthenia—Methotrexate—colon cancer	0.000204	0.000668	CcSEcCtD
Bosentan—Pruritus—Methotrexate—colon cancer	0.000201	0.000659	CcSEcCtD
Bosentan—Diarrhoea—Methotrexate—colon cancer	0.000194	0.000637	CcSEcCtD
Bosentan—Dizziness—Methotrexate—colon cancer	0.000188	0.000616	CcSEcCtD
Bosentan—Vomiting—Methotrexate—colon cancer	0.000181	0.000592	CcSEcCtD
Bosentan—Rash—Methotrexate—colon cancer	0.000179	0.000587	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—colon cancer	0.000179	0.000587	CcSEcCtD
Bosentan—Headache—Methotrexate—colon cancer	0.000178	0.000584	CcSEcCtD
Bosentan—Nausea—Methotrexate—colon cancer	0.000169	0.000553	CcSEcCtD
